Cresset Asset Management LLC Reduces Stock Position in iShares Biotechnology ETF $IBB

Cresset Asset Management LLC lowered its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 6.5% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 10,627 shares of the financial services provider’s stock after selling 734 shares during the period. Cresset Asset Management LLC’s holdings in iShares Biotechnology ETF were worth $1,359,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the stock. Kovitz Investment Group Partners LLC raised its holdings in iShares Biotechnology ETF by 126.2% in the 1st quarter. Kovitz Investment Group Partners LLC now owns 4,107 shares of the financial services provider’s stock worth $525,000 after purchasing an additional 2,291 shares in the last quarter. Ted Buchan & Co raised its holdings in iShares Biotechnology ETF by 32.9% in the 1st quarter. Ted Buchan & Co now owns 3,515 shares of the financial services provider’s stock worth $450,000 after purchasing an additional 870 shares in the last quarter. Finer Wealth Management Inc. raised its holdings in iShares Biotechnology ETF by 9.2% in the 1st quarter. Finer Wealth Management Inc. now owns 9,361 shares of the financial services provider’s stock worth $1,197,000 after purchasing an additional 785 shares in the last quarter. SouthState Corp raised its holdings in iShares Biotechnology ETF by 269.5% in the 1st quarter. SouthState Corp now owns 303 shares of the financial services provider’s stock worth $39,000 after purchasing an additional 221 shares in the last quarter. Finally, Berger Financial Group Inc raised its holdings in iShares Biotechnology ETF by 15.0% in the 1st quarter. Berger Financial Group Inc now owns 2,980 shares of the financial services provider’s stock worth $381,000 after purchasing an additional 389 shares in the last quarter. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ IBB opened at $138.42 on Thursday. iShares Biotechnology ETF has a 12 month low of $107.43 and a 12 month high of $150.57. The firm has a fifty day simple moving average of $131.30 and a two-hundred day simple moving average of $128.89.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.